戻る Agenda
Keynote Address 2
Session Chair(s)
Tatsuo Kurokawa, DIAFellow, PHD
Director General
The Japan Biosimilar Association, Japan
Dr. Hamburg has provided significant contributions towards the promotion of US FDA as Commissioner through various efforts including the launch of Advancing Regulatory Science Initiative. She has also been contributing actively to international collaboration in regulatory science and involved in the launch of a forum for regulatory science discussions among regulators from all countries. She will share her thoughts and efforts about regulatory science.
Speaker(s)
TBC
Margaret A. Hamburg, MD
NTI | bio Advisory Group, United States
Interim Vice President, Global Biological Policy and Programs; Chair